About this trial

This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.

Eligibility criteria

Qualifiers

age 18 - 65 years old;

Diagnosis of F20, F25 or F21 according to ICD-10;

Signed informed consent form.

Disqualifiers

Age younger than 18 or older than 65 years old;

Did not sign the informed consent form;

Legally inactive person

Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79);

Trial design

Treatments tested in this trial

  • Brief Negative Symptoms Scale
  • The Calgary Depression Scale for Schizophrenia
  • The Schizophrenia Cognition Rating Scale

Treatment groups

No treatment groups listed

Locations

2
Jonas MontvidasLT-53137, Kaunas Lithuania
Lithuanian University of Health Sciences Hospital Kaunas ClinicsLT-50161, Kaunas Lithuania

Sponsors and collaborators

Lithuanian University of Health Sciences

Lead sponsor